Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Muntean

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Thrombosis Research|April 4, 1998
Longer aPTT values in healthy children than in adults: no single causeS Gallistl, W Muntean, B Leschnik, et al.
Wiener Klinische Wochenschrift|July 9, 1982
[Fetal alcohol syndrome and malignant tumors]H Becker, A Zaunschirm, W Muntean, et al.
Klinische Padiatrie|August 1, 2006
[Pernio as cause of a blue toe syndrome]K Pfurtscheller, R Kerbl, M Hanzer, et al.
Journal of Pediatric Orthopedics|January 16, 1999
The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes diseaseS Gallistl, T Reitinger, W Linhart, et al.
Thrombosis Research|October 29, 2000
A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiencyR Dodojacek, G Höfler, B Leschnik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2013
Port-A-Cath infection causes inhibitor recurrence after initial successful ITIG Grangl, S Gallistl, B Leschnik, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonatesG Cvirn, S Gallistl, B Leschnik, et al.
Wiener Klinische Wochenschrift|January 4, 1985
[Ultrasound diagnosis of malignant diseases in pediatrics]G Maurer, C Urban, W Muntean, et al.
Thrombosis and Haemostasis|June 1, 1997
Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombinW Muntean, W Zenz, G Edlinger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 20, 2002
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBAS Gallistl, G Cvirn, B Leschnik, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Thrombosis Research|April 4, 1998
Longer aPTT values in healthy children than in adults: no single causeS Gallistl, W Muntean, B Leschnik, et al.
Wiener Klinische Wochenschrift|July 9, 1982
[Fetal alcohol syndrome and malignant tumors]H Becker, A Zaunschirm, W Muntean, et al.
Klinische Padiatrie|August 1, 2006
[Pernio as cause of a blue toe syndrome]K Pfurtscheller, R Kerbl, M Hanzer, et al.
Journal of Pediatric Orthopedics|January 16, 1999
The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes diseaseS Gallistl, T Reitinger, W Linhart, et al.
Thrombosis Research|October 29, 2000
A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiencyR Dodojacek, G Höfler, B Leschnik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2013
Port-A-Cath infection causes inhibitor recurrence after initial successful ITIG Grangl, S Gallistl, B Leschnik, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonatesG Cvirn, S Gallistl, B Leschnik, et al.
Wiener Klinische Wochenschrift|January 4, 1985
[Ultrasound diagnosis of malignant diseases in pediatrics]G Maurer, C Urban, W Muntean, et al.
Thrombosis and Haemostasis|June 1, 1997
Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombinW Muntean, W Zenz, G Edlinger, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 20, 2002
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBAS Gallistl, G Cvirn, B Leschnik, et al.
Pageof 14